Our faculty have backgrounds in epidemiology, health economics and health services research; represent four of the six academic colleges at UF Health, and are here to develop new methods and analytical tools that will enhance dug evaluation and regulatory science.
Meet the CoDES research team:
Dr. Antonelli’s research focuses on otologic implant infections, prevention of tympanostomy tube occlusion, prevention of iatrogenic hearing loss and medical errors.
Dr. Brumback is the Professor and Associate Chair of the Department of Biostatistics. Her research interests include both bio statistics and public health and medical studies.
Dr. Cavallari’s research involves discovery and clinical translation of genetic variants related to drug response and has been funded by the NIH, FDA, American Heart Association and more.
Dr. Diaby’s research with pharmaceutical outcomes & Economic Evaluation, HTA, Pharmacoeconomics, MSDA, and Policy Evaluations. policy includes:
Dr. Hincapie-Castillo’s research interests include drug utilization and safety in pain management, pharmacoepidemiology, and health services research and legal epidemiology.
Dr. Goodin is an Assistant Professor with Pharmaceutical Outcomes & Policy. Her research focuses on mixed-method approaches and their impact of policy change on populations that face health disparities.
Dr. Lo-Ciganic’s research interest focuses on drug safety, medication adherence, prescription drug abuse and quality, and value of prescribing.
Dr. Park’s research revolves around economic and health outcomes of medication studies, pharmaceutical care services and pharmaceutical policies.
Dr. Schmidt’s research centers on the application of Pharmacometrics and Systems Pharmacology tools to address clinically relevant research in antimicrobial chemotherapy, pediatrics, diabetes, cardiovascular safety and post-menopausal osteoporosis.
Dr. Segal is the associate dean for Faculty Affairs and a professor of Pharmaceutical Outcomes & Policy. He is widely recognized for his work in explaining why clinical practice is so often inconsistent with evidence-based practice.
Dr. Smith is an Assistant Professor in the Departments of Pharmacotherapy and Translational Research and Community Health & Family Medicine. His research focuses on cardiovascular pharmacotherapy and hypertension.
Dr. Tighe’s research centers on machine and deep learning algorithms, decision and process modeling and social network analyses related to improving pain, cognitions and perioperative patient safety.
Dr. Vouri is a clinical assistant professor in Pharmaceutical Outcomes & Policy and assistant director of pPhmaracy Services.
Dr Wei’s research includes Pharmacoepidemiology, Geriatric medication use, Medication prescribing and safety for nursing homes.